摘要 |
Compounds of Formula (I) in free or salt form, wherein Ra, Rb, R2, R3, R 4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinositol 3-kinase such as inflammatory airway diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
|